A molecular barcode and web-based data analysis tool to identify imported Plasmodium vivax malaria

• Autor(a) principal: Trimarsanto, Hidayat
• Data de Publicação: 2022
• Outros Autores: Amato, Roberto, Pearson, Richard D., Sutanto, Edwin, Noviyanti, Rintis, Trianty, Leily, Marfurt, Jutta, Pava, Zuleima, Echeverry, Diego F., Lopera-Mesa, Tatiana M., Montenegro, Lidia M., Tobón-Castaño, Alberto, Grigg, Matthew J., Barber, Bridget, William, Timothy, Anstey, Nicholas M., Getachew, Sisay, Petros, Beyene, Aseffa, Abraham, Assefa, Ashenafi, Rahim, Awab G., Chau, Nguyen H., Hien, Tran T., Alam, Mohammad S., Khan, Wasif A., Ley, Benedikt, Thriemer, Kamala, Wangchuck, Sonam, Hamedi, Yaghoob, Adam, Ishag, Liu, Yaobao, Gao, Qi, Sriprawat, Kanlaya, Ferreira, Marcelo U., Laman, Moses, Barry, Alyssa, Mueller, Ivo, Lacerda, Marcus V.G., Llanos-Cuentas, Alejandro, Krudsood, Srivicha, Lon, Chanthap, Mohammed, Rezika, Yilma, Daniel, Pereira, Dhelio B., Espino, Fe E.J., Chu, Cindy S., Vélez, Iván D., Namaik-larp, Chayadol, Villegas, Maria F., Green, Justin A.
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: http://hdl.handle.net/10362/148961
• topic: Plasmodium vivax; barcode; Malaria/epidemiology; SNPs; RA0421 Public health. Hygiene. Preventive Medicine; Medicine (miscellaneous); Biochemistry, Genetics and Molecular Biology(all); Agricultural and Biological Sciences(all); Epidemiology; SDG 3 - Good Health and Well-being; SDG 1 - No Poverty; SDG 6 - Clean Water and Sanitation

Funding Information: We would like to thank the patients who contributed their samples to the study, and the health workers and field teams who assisted with the sample collections. We also thank the staff of the Wellcome Sanger Institute Sample Logistics, Sequencing, and Informatics facilities for their contributions. For the purpose of open access, the author has applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission. This research was funded in part by the Wellcome Trust (Senior Fellowship in Clinical Science awarded to R.N.P., 200909). The research was also funded in part by the Australian Department of Foreign Affairs and Trade (TDCRRI 72904), the Australian National Health and Medical Research Council (NHMRC) (APP2001083 awarded to S.A.), and the Bill and Melinda Gates Foundation (OPP1164105). H.T. was supported by a Charles Darwin University International PhD Scholarship (CDIPS). The patient sampling and metadata collection was funded by the Asia-Pacific Malaria Elimination Network (108-07), the Malaysian Ministry of Health (BP00500420), and the NHMRC (1037304 and 1045156; Fellowships to N.M.A. [1042072 and 1135820], B.E.B. [1088738] and M.J.G. [1074795]). M.J.G was also supported by a ‘Hot North’ Earth Career Fellowship (1131932). M.U.F is supported by a senior researcher scholarship from the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Brazil. The whole genome sequencing component of the study was supported by grants from the Medical Research Council and UK Department for International Development (M006212) and the Wellcome Trust (204911) awarded to D.P.K., and a Wellcome Trust grant (206194/Z/17/Z) awarded to D.P.K. and J.C.R. This work was supported by the Australian Centre for Research Excellence on Malaria Elimination (ACREME), funded by the NHMRC (APP 1134989). Publisher Copyright: © 2022, The Author(s).